Adcentrx Therapeutics is a biotechnology company focused on accelerating breakthroughs in developing protein conjugate therapeutics for cancer and other life-threatening diseases.
Location: United States, California, San Diego
Total raised: $38M
Investors 2
Date | Name | Website |
- | F-Prime Ca... | fprimecapi... |
27.04.2023 | Eight Road... | eightroads... |
Funding Rounds 1
Date | Series | Amount | Investors |
25.04.2023 | Series A | $38M | - |
Mentions in press and media 11
Date | Title | Description | Source |
06.12.2023 | Adcentrx Extends Series A+ Financing to $51M | Adcentrx Therapeutics, a San Diego, CA- and Shanghai, China-based biotechnology company dedicated to... | finsmes.co... |
05.12.2023 | Adcentrx extends Series A+ Funding to $51M to boost developm... | - | connect.or... |
25.04.2023 | Our investment in Adcentrx Therapeutics | Adcentrx Therapeutics (“Adcentrx”), a biotechnology company dedicated to revolutionizing Antibody-Dr... | eightroads... |
25.04.2023 | Adcentrx Therapeutics Closes $38M Series A+ | SAN DIEGO, CA, Adcentrx Therapeutics announces the closing of a $38 million Series A+ financing. ... | vcnewsdail... |
25.04.2023 | Adcentrx Therapeutics Raises $38M | San Diego-based Adcentrx Therapeutics, a biotech company which is focused on treatments for cancer a... | socaltech.... |
25.04.2023 | Adcentrx Therapeutics Closes $38M Series A+ Financing | Adcentrx Therapeutics, a San Diego, CA and Shangai, China-based biotechnology company dedicated to a... | finsmes.co... |
25.04.2023 | Adcentrx Therapeutics closes $38M Series A round to advance ... | - | connect.or... |
24.04.2023 | Adcentrx Therapeutics Announces Completion of $38 million Se... | - | fprimecapi... |
- | Adcentrx Therapeutics Announces Completion of $50m Series A ... | SHANGHAI and SAN DIEGO, Calif., April 28, 2021 /PRNewswire/ -- Adcentrx Therapeutics ("Adcentrx... | cbridgecap... |
- | Adcentrx Therapeutics | “Adcentrx Therapeutics is a biotechnology company focused on accelerating breakthroughs in developin... | fastfounde... |
Show more